Abstract
Whereas the GTPase RhoA has been shown to promote proliferation and malignant transformation, the involvement of RhoB in these processes is not well understood. In this manuscript RhoB is shown to be a potent suppressor of transformation and human tumor growth in nude mice. In several human cancer cell lines, RhoA promotes focus formation whereas RhoB is as potent as the tumor suppressor p53 at inhibiting transformation in this assay. RhoB is both farnesylated (F) and geranylgeranylated (GG), and RhoB-F has been suggested as a target for the antitumor activity of farnesyltransferase inhibitors. Here we demonstrate that both RhoB-F and RhoB-GG inhibit anchorage-dependent and -independent growth, induce apoptosis, inhibit constitutive activation of Erk and insulin-like growth factor-1 stimulation of Akt, and suppress tumor growth in nude mice. The data demonstrate that RhoB is a potent suppressor of human tumor growth and that RhoB-F is not a target for farnesyltransferase inhibitors.
Highlights
Low molecular weight GTP/GDP-binding GTPases such as Ras and Rho transduce mitogenic and survival signals from cell surface receptor to the nucleus [1,2,3]
Ras triggers a complex set of signal transduction pathways. These include the phosphatidylinositol 3-kinase/Akt pathway believed to be critical for cell survival and the Raf/Mek/Erk kinase cascade that has been implicated in cell proliferation [1,2,3]
RhoB is an immediate early response gene that is induced by platelet-derived growth factor, transforming growth factor-␣, the non-receptor tyrosine kinase v-Src, and ultraviolet irradiation [3, 10, 11]
Summary
Low molecular weight GTP/GDP-binding GTPases such as Ras and Rho transduce mitogenic and survival signals from cell surface receptor to the nucleus [1,2,3]. In several human cancer cell lines, RhoA promotes focus formation whereas RhoB is as potent as the tumor suppressor p53 at inhibiting transformation in this assay.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.